Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008739

Chief Executive Officer bought 1,500 shares at $20.00 ($30,000)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schatzman Randall C Chief Executive Officer 2021-02-09 Purchase +1,500 $20.00 $30,000 1,500 D: show line 1 in the form
Open-market purchases · 1,500 sh · avg $20.00 · $30,000
Loading xslF345X03/doc4.xml…